跳至主要内容
临床试验/JPRN-UMIN000046107
JPRN-UMIN000046107已完成未知

Impact of diuretics use in long-term management of congestive heart failure patients to prevent re-hospitalization using the Diagnosis Procedure Combination Database - Impact of diuretics use in long-term management of congestive heart failure patients to prevent re-hospitalization using the Diagnosis Procedure Combination Database

Otsuka Pharmaceutical Co., Ltd. Medical Affairs Department0 个研究点目标入组 11,257 人开始时间: 2021年11月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
11,257

研究概览

简要总结

In this study, compared to loop diuretics, additional tolvaptan treatment was not shown to be effective for the time to readmission due to heart failure. Re-hospitalization for heart failure has been shown to be associated with age, Na, creatinine, and prescriptions of ACE inhibitors or ARBs and thiazides. On the other hand, additional treatment with tolvaptan was shown to be significantly longer in terms of time to in-hospital death.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients younger than 20 years at the time of the second hospitalization for the disease of interest

研究者

发起方
Otsuka Pharmaceutical Co., Ltd. Medical Affairs Department

相似试验

Impact of diuretics use in long-term management of... | 临床试验